Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com164d agoneutral
S&P 500, Nasdaq Rise to Another Record. Software Strikes Back.Insider Monkey167d agoneutral
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology PortfolioStocktwits170d agobullish
GILD Stock Jumps After Winning Accelerated FDA Approval For HDV TreatmentSimply Wall St.176d agobullish
Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority ReviewBarrons.com178d agobullish
Tomato Prices Aren’t the Only Problem. How Retirees Can Beat Inflation.Simply Wall St.183d agoneutral
Stronger HIV Pipeline And Acquisition Charges Might Change The Case For Investing In Gilead Sciences (GILD)MT Newswires184d agoneutral
Gilead Sciences' Increased Yeztugo Guidance is 'Good Enough' for the Stock, Morgan Stanley SaysBarrons.com185d agobearish
Gilead Earnings Show HIV Drugs Continue to Shine. Why the Guidance Cut?The Wall Street Journal185d agoneutral
Gilead Sciences Expects Loss This Year on Acquired R&D ExpensesInvestor's Business Daily185d agoneutral
Gilead Tumbles On Mixed Guidance Update Amid Recent M&A FrenzyReuters185d agobearish
Gilead raises 2026 sales forecast, cuts profit outlook due to acquisitions